Moreover, degarelix induced relief of LUTS in patients with PCa, and this improvement was more effective and occurred over a longer period in a higher percentage of patients than goserelin, a GnRH agonist [11,17,19]. The gene discussed is GNRH1; the disease is posterior cortical atrophy.